Bexsero (meningococcal group B) is a vaccine used to prevent meningitis B. Bexsero can cause side effects that range from mild to serious. Examples include injection site redness and pain, muscle ...

Novartis AG's Bexsero vaccine helps protect toddlers against the most common cause of meningitis when used as a booster, the Swiss drugmaker said on Thursday, giving its meningitis franchise ...

Bexsero, a meningococcal B vaccine approved in the United States since 2015, induces antibodies in humans that target Neisseria gonorrhoeae, indicating that it may offer cross-protection against ...

Bexsero is a vaccine used to prevent meningitis B. Find out what the recommended dosage is, its schedule, how the vaccine is given, and more.

Bexsero is the only meningitis B vaccine approved in the US with a two-dose regimen and a flexible dosing schedule [1]. As part of the accelerated approval process, ...

(Bexsero is a vaccine that’s given as an intramuscular injection.) For example, some people experienced hardening of the skin where the injection was given.

Basel, June 9, 2011 - New data from a pivotal study in more than 1,800 infants show that Novartis candidate vaccine Bexsero® (Multicomponent Meningococcal Serogroup B Vaccine) induces a robust ...

Bexsero is a brand-name vaccine used to help prevent meningitis B disease. Discover drug interactions in depth, when to avoid Bexsero, and more.

Bexsero protects against meningitis B, one of the serotypes of Neisseria meningitidis bacteria. It is closely related to Neisseria gonorrhoeae; the genetic sequences of the two are between 80% and ...

Based on new immunogenicity data, the FDA changed the label for the Bexsero MenB-4C vaccine from a 2-dose schedule at intervals of 0 and at least 1 month to a 2-dose schedule at intervals of 0 and ...

WebMD's guide to the meningococcal vaccine, who needs it, when it is given, and possible side effects.

The vaccine combines the antigenic components of GSK’s two well-established meningococcal vaccines, Bexsero (Meningococcal Group B Vaccine) and Menveo (Meningococcal [Groups A, C, Y, and W-135 ...